Schematic comparison between conventional oxidation and contaminant-assisted synergistic oxidation. In the baseline Mn(VII)/chlorite system, short-lived manganese intermediates lead to limited ...
X-TOLE2 met primary endpoint in both dose groups, including -53.2% median percent change (MPC) from baseline in monthly FOS frequency with 25 mg dose compared with -10.4% for placebo (p=0.000000000006 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results